Oakes Benjamin L.'s Form 4 filing
Scribe Therapeutics, Inc. (SCTX) · filed Jul 27, 2026
- Accession no.
- 0002127814-26-000004
- Filed
- Jul 27, 2026, 9:26 PM ET
- Trade date
- Mar 13-Jul 23, 2026
- Filing delay
- 136 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 derivative transactions. It was filed 136 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oakes Benjamin L.CIK 0002127814 | Director, Officer (President, CEO), Other: Chairman of the Board |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Common Stock | AGrant or awardAcquired | +12,969 | $0.00 | $0 | 12,969 | Direct | |
| Jul 23, 2026 | Common Stock | AGrant or awardAcquired | +264,784 | $0.00 | $0 | 264,784 | Direct | |
| Jul 23, 2026 | Common Stock | AGrant or awardAcquired | +429,599 | $0.00 | $0 | 429,599 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.